Anthropic's S-1: $16.3B H1 revenue, 900% NRR, and medicine first
HealthcareAIGuy · x · 2026-10-26
Anthropic filed its S-1 ahead of its IPO, revealing: $16.3B revenue in H1 2026 (up 14x YoY), operating loss down to $693M from $2.1B, $9B compute spending, 11,900+ customers spending $100K+/year, 1,900+ above $1M, 250 above $10M, and 900% net revenue retention. Notably, the S-1 lists biology and medicine first among applications with the greatest potential to improve human life: curing cancer, Alzheimer's, heart disease and rare genetic diseases; compressing clinical trial reports from months to minutes; accelerating drug discovery with pharma partners; and AI-powered malaria modeling. One of the fastest-growing AI companies is putting medicine at the center of its vision.
Related event: Anthropic Files S-1 to Kick Off IPO Under Ticker ANT on Nasdaq(71 posts)→
More from Companies & People
- Stanford HAI's Human-Centered AI for Social Impact program wraps third cohort — StanfordHAI · 2026-10-27
- Goodfire commits $10M to a 'Human Genome Project for AI' to reverse-engineer frontier models — CatAstro_Piyush · 2026-10-27
- SF 'Code Engineering' event picks up where 1,000-person harness engineering meetup left off — LangChain · 2026-10-27
- Anthropic reveals it bans customers worth 5-7% of revenue every 9 months — Polymarket · 2026-10-27
- Anthropic's IPO Filing Goes Public, Revealing Strong Revenue and Massive Spending — KateClarkTweets · 2026-10-27
- OpenAI Foundation funds UNC tumor antigen project, hiring senior experimental scientist — iskander · 2026-10-27